Deep Genomics

2021 Series C Biotechnology Raised $180,000,000
Industry
Biotechnology
Stage
Series C
Raised
$180,000,000

Company Overview

Deep Genomics the company operates an AI-powered genetic medicine discovery tool with a focus on interpreting genetic variation. Leveraging high-throughput assays and advanced robotics systems, their AI platform generates billions of data points and constructs numerous engineered and validated machine learning systems. These systems play a crucial role in supporting drug development by assisting researchers in classifying, prioritizing, interpreting, and establishing connections among genetic variants, both natural and therapeutic.

Pitch Deck

Market Opportunity

Discover the market opportunity in the Biotechnology industry. Learn about market size, growth potential, and competitive landscape.

Explore Market Research →

Similar Companies

View pitch decks from other series c companies in the Biotechnology industry.

View Similar Pitch Decks →

Resources & Tips

Pitch Deck Best Practices

Learn how to create an effective pitch deck that resonates with investors.

Read Guide →

Fundraising Strategy

Get insights on fundraising strategies for series c startups.

Learn More →

Find Investors

Connect with investors interested in Biotechnology startups.

Browse Investors →